ClinConnect ClinConnect Logo
Search / Trial NCT06436508

The Investigation of the Impact of Early Mobilization on the Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage.

Launched by UNIVERSITY OF PECS · May 30, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Subarachnoid Hemorrhage Early Mobilization

ClinConnect Summary

This clinical trial is looking at how early movement, or mobilization, affects recovery in patients who have experienced a type of bleeding in the brain called subarachnoid hemorrhage, which is often caused by a burst aneurysm. The researchers want to see if getting patients up and moving sooner, compared to just resting in bed, can lead to better health outcomes. They will be comparing two groups: one that starts moving early and another that follows the standard care of staying in bed.

To participate in this trial, individuals need to be at least 18 years old and have a certain level of health before their brain injury. They should also have had their aneurysm treated and must enroll within 72 hours after the bleeding starts. Participants can expect to either begin moving around shortly after their treatment or continue with standard bed rest care. It’s important to know that this study is currently recruiting, and anyone interested should review the eligibility criteria or speak with their healthcare provider for more information.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \>18 ys
  • Premorbid modified Rankin Scale score of 0-2
  • WFNS I-IV at enrollment
  • Aneurysm occlusion has occurred through open or endovascular means
  • Minimum 24 hours elapsed after aneurysm occlusion
  • The patient has not received thrombolytic therapy
  • Vital parameters are appropriate (mean arterial pressure \[MAP\] \>80 or \>110 mm Hg)
  • Signed patient information and consent form
  • Enrollment occurs within 72 hours following ictus
  • Exclusion Criteria:
  • Age under 18 years
  • Traumatic subarachnoid hemorrhage
  • Incapacitated or limited capacity for action before ictus
  • Confirmed pregnancy
  • Aneurysm multiplicity (unless all aneurysms are treated)

About University Of Pecs

The University of Pécs, a prestigious institution located in Hungary, is dedicated to advancing medical research and education through its innovative clinical trial initiatives. Renowned for its commitment to scientific excellence and interdisciplinary collaboration, the university actively engages in clinical studies that aim to improve patient outcomes and enhance healthcare practices. With a focus on ethical standards and rigorous methodologies, the University of Pécs leverages its experienced faculty and state-of-the-art facilities to contribute valuable insights to the global medical community.

Locations

Pécs, Baranya, Hungary

Miskolc, Baz, Hungary

Budapest, , Hungary

Patients applied

0 patients applied

Trial Officials

Peter Csecsei, MD. PhD

Principal Investigator

University of Pecs

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported